Publications in collaboration with researchers from Hospital General Universitario Gregorio Marañón (120)

2025

  1. Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case–Control Analysis from the First Episode Case–Control EU-GEI WP2 Study: L’arrêt de l’utilisation du cannabis et le risque de troubles psychotiques: Une analyse cas-témoins tirée de l’étude cas-témoins EU-GEI WP2 centrée sur les premiers épisodes psychotiques

    Canadian Journal of Psychiatry, Vol. 70, Núm. 3, pp. 182-193

  2. Cognitive presentation at psychosis onset through premorbid deterioration and exposure to environmental risk factors

    Psychological Medicine, Vol. 55

  3. Methylomic signature of current cannabis use in two first-episode psychosis cohorts

    Molecular Psychiatry, Vol. 30, Núm. 4, pp. 1277-1286

  4. Variation of subclinical psychosis as a function of population density across different European settings: Findings from the multi-national EU-GEI study

    Acta Psychiatrica Scandinavica, Vol. 151, Núm. 4, pp. 506-520

2024

  1. Accelerated Cortical Thinning in Schizophrenia Is Associated With Rare and Common Predisposing Variation to Schizophrenia and Neurodevelopmental Disorders

    Biological Psychiatry, Vol. 96, Núm. 5, pp. 376-389

  2. Basic quality indicators for clinical care of patients with major depression, schizophrenia, and bipolar disorder

    Spanish Journal of Psychiatry and Mental Health, Vol. 17, Núm. 2, pp. 103-109

  3. Cannabis use and cognitive biases in people with first-episode psychosis and their siblings

    Psychological Medicine

  4. Clustering Schizophrenia Genes by Their Temporal Expression Patterns Aids Functional Interpretation

    Schizophrenia Bulletin, Vol. 50, Núm. 2, pp. 327-338

  5. Processing speed mediates the relationship between DDR1 and psychosocial functioning in euthymic patients with bipolar disorder presenting psychotic symptoms

    Molecular Psychiatry, Vol. 29, Núm. 7, pp. 2050-2058

  6. Self-reported suicidal ideation among individuals with first episode psychosis and healthy controls: Findings from the international multicentre EU-GEI study

    Schizophrenia Research, Vol. 270, pp. 339-348

  7. The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study

    Schizophrenia Bulletin, Vol. 50, Núm. 5, pp. 1039-1049

  8. The effect of polygenic risk score and childhood adversity on transdiagnostic symptom dimensions at first-episode psychosis: evidence for an affective pathway to psychosis

    Translational Psychiatry, Vol. 14, Núm. 1

  9. The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies

    Psychological Medicine

  10. Variation of subclinical psychosis across 16 sites in Europe and Brazil: findings from the multi-national EU-GEI study

    Psychological medicine, Vol. 54, Núm. 8, pp. 1810-1823

2023

  1. Basic quality indicators for clinical care of patients with major depression, schizophrenia, and bipolar disorder

    Revista de Psiquiatria y Salud Mental

  2. Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: Results from the EU-GEI case-control study

    Psychological Medicine, Vol. 53, Núm. 15, pp. 7375-7384

  3. Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study

    Psychological Medicine, Vol. 53, Núm. 13, pp. 6150-6160

  4. Development and Validation of Predictive Model for a Diagnosis of First Episode Psychosis Using the Multinational EU-GEI Case-control Study and Modern Statistical Learning Methods

    Schizophrenia Bulletin Open, Vol. 4, Núm. 1

  5. Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study

    Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280

  6. Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study

    Psychiatry Research, Vol. 323